Beyond Approval: The Hidden Risk in Biotech Stocks
What happens after regulatory approval? The overlooked risks biotech companies face post-approval—and why even promising drugs can stumble after reaching the market.
Tariff Shocks and Portfolio Lessons: Navigating Uncertainty in a Volatile Market
In early April, amid rising geopolitical tensions and economic uncertainty, I made the decision to reduce my exposure to certain consumer discretionary and tech stocks in my portfolio – one of them being Alphabet, the parent company of Google.
The short story of my website and personal brand
After experimenting with social media platforms, I found their formats a bit limiting. I wanted a space that offered more creative freedom – a place to fully express and unify my diverse roles and interests in science, art and design. This led
